Literature DB >> 17968970

Serum protein patterns in newly diagnosed type 2 diabetes mellitus--influence of diabetic environment and family history of diabetes.

Tea Sundsten1, Claes-Göran Ostenson, Peter Bergsten.   

Abstract

BACKGROUND: Individuals with normal glucose tolerance (NGT) and type 2 diabetes mellitus (T2DM) represent heterogeneous groups with differences in beta-cell function and genetic background. The aim of the present study was to compare serum protein profiles of NGT and T2DM individuals and determine the influence of the genetic background versus diabetic environment on differentially displayed proteins.
METHODS: Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) was used to compare serum protein profiles of NGT persons and T2DM patients. All participants were from the Stockholm Diabetes Prevention Program (SDPP) cohort. They were selected to have high or low beta-cell function (HOMA-beta) and family history of type 2 diabetes (FHD) or not.
RESULTS: Eight proteins were found to be elevated and five lowered (p<0.05) in serum of T2DM patients. In a second comparison, the NGT and T2DM groups were divided into persons with FHD and low HOMA-beta and those without FHD and high HOMA-beta. Three proteins were rediscovered and interpreted to be different due to genetic background. Two of these were identified as apolipoprotein C3 (apoC3) and albumin. Ten proteins were interpreted to be not related to FHD, and one of these was identified as transthyretin.
CONCLUSIONS: Using the SELDI-technique, serum protein profiles of NGT and T2DM persons with differences in beta-cell function and FHD were compared. The diabetic environment had a major influence on most of these proteins, while FHD was an important factor for apoC3 and albumin. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17968970     DOI: 10.1002/dmrr.789

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  8 in total

Review 1.  Transthyretin: the servant of many masters.

Authors:  Joel N Buxbaum; Natàlia Reixach
Journal:  Cell Mol Life Sci       Date:  2009-07-31       Impact factor: 9.261

2.  Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src.

Authors:  Yue Shi; Guang Yang; Jia Yu; Lina Yu; Ruth Westenbroek; William A Catterall; Lisa Juntti-Berggren; Per-Olof Berggren; Shao-Nian Yang
Journal:  Cell Mol Life Sci       Date:  2013-08-15       Impact factor: 9.261

3.  Association between protein signals and type 2 diabetes incidence.

Authors:  Troels Mygind Jensen; Daniel R Witte; Damiana Pieragostino; James N McGuire; Ellis D Schjerning; Chiara Nardi; Andrea Urbani; Mika Kivimäki; Eric J Brunner; Adam G Tabàk; Dorte Vistisen
Journal:  Acta Diabetol       Date:  2012-02-05       Impact factor: 4.280

Review 4.  Analysing the nanoparticle-protein corona for potential molecular target identification.

Authors:  Chandra Kumar Elechalawar; Md Nazir Hossen; Lacey McNally; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  J Control Release       Date:  2020-03-09       Impact factor: 9.776

5.  HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study.

Authors:  Rain Yamamoto; Majken K Jensen; Sarah Aroner; Jeremy D Furtado; Bernard Rosner; Frank B Hu; Beverley Balkau; Andrea Natali; Ele Ferrannini; Simona Baldi; Frank M Sacks
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

6.  Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population.

Authors:  Xiaoli Hu; Qianqian Guo; Xiaoqian Wang; Qiang Wang; Liangkai Chen; Taoping Sun; Peiyun Li; Zhilei Shan; Liegang Liu; Chao Gao; Ying Rong
Journal:  Nutrients       Date:  2022-07-19       Impact factor: 6.706

7.  Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells.

Authors:  E-ri M Sol; Tea Sundsten; Peter Bergsten
Journal:  Lipids Health Dis       Date:  2009-02-05       Impact factor: 3.876

8.  Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.

Authors:  Richard Killick; Georgie Scales; Karelle Leroy; Mirsada Causevic; Claudie Hooper; Elaine E Irvine; Agharul I Choudhury; Laura Drinkwater; Fiona Kerr; Hind Al-Qassab; John Stephenson; Zehra Yilmaz; K Peter Giese; Jean-Pierre Brion; Dominic J Withers; Simon Lovestone
Journal:  Biochem Biophys Res Commun       Date:  2009-06-10       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.